Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s share price rose 3.4% during trading on Wednesday . The stock traded as high as C$1.57 and last traded at C$1.50. Approximately 159,808 shares traded hands during mid-day trading, an increase of 60% from the average daily volume of 99,597 shares. The stock had previously closed at C$1.45.
Cardiol Therapeutics Stock Performance
The company has a market cap of C$125.59 million, a P/E ratio of -3.13 and a beta of 0.95. The company has a quick ratio of 6.84, a current ratio of 2.49 and a debt-to-equity ratio of 1.59. The stock has a 50 day moving average price of C$1.71 and a two-hundred day moving average price of C$1.64.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- How to buy stock: A step-by-step guide for beginnersÂ
- Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
- ETF Screener: Uses and Step-by-Step Guide
- Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
- What is a Secondary Public Offering? What Investors Need to Know
- Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
